Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)
|
December 13, 2024
Isomeric Cu(I) Azolate Frameworks Showing Contrasting Electrocatalytic CO<sub>2</sub> Reduction Selectivities and Stabilities
Kai Zheng, Ding-Yi Hu, Chao Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Pengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Angewandte Chemie (International Ed. in English)
|
May 5, 2022
Flexible Cuprous Triazolate Frameworks as Highly Stable and Efficient Electrocatalysts for CO<sub>2</sub> Reduction with Tunable C<sub>2</sub> H<sub>4</sub> /CH<sub>4</sub> Selectivity
Lin-Ling Zhuo, Pin Chen, Kai Zheng, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
February 25, 2025
Research progress on the mechanism and treatment of cachexia based on tumor microenvironment
Bochen Zhao, Gege Shi, Jiaxin Shi, et al.
Journal of Pharmaceutical Analysis
|
March 27, 2026
A novel proteolysis-targeting chimera strategy targeting multiple immune checkpoints containing ITIMs enhances antitumor immunity
Yue-Yuan Qiu, Zhao-Wei Wang, Lei He, et al.
Cell Communication and Signaling : CCS
|
October 15, 2025
GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinoma
Gege Shi, Wangqian Zhang, Fei Xie, et al.
Biochemical Pharmacology
|
January 20, 2026
Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunity
Maorong Zhu, Yuxin Wu, Kuo Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 5, 2024
Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
Lei He, Zhaozhao Li, Danjie Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 19, 2026
Uncomplicated Choledocholithiasis in Elderly Patients: A Target Trial Emulation Comparing Observation and ERCP (CHOIcE)
Zachary L Smith, Tasmia Amjad, Mikaela Hoard, et al.
Lancet Regional Health. Americas
|
December 26, 2025
The longitudinal effect of repetition and practice on the accuracy of lay anal examinations for detecting perianal and anal canal abnormalities: a prospective study
Alan G Nyitray, Timothy L McAuliffe, Jenna Nitkowski, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Small (Weinheim an Der Bergstrasse, Germany)
|
December 13, 2024
Isomeric Cu(I) Azolate Frameworks Showing Contrasting Electrocatalytic CO<sub>2</sub> Reduction Selectivities and Stabilities
Kai Zheng, Ding-Yi Hu, Chao Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Pengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Angewandte Chemie (International Ed. in English)
|
May 5, 2022
Flexible Cuprous Triazolate Frameworks as Highly Stable and Efficient Electrocatalysts for CO<sub>2</sub> Reduction with Tunable C<sub>2</sub> H<sub>4</sub> /CH<sub>4</sub> Selectivity
Lin-Ling Zhuo, Pin Chen, Kai Zheng, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
February 25, 2025
Research progress on the mechanism and treatment of cachexia based on tumor microenvironment
Bochen Zhao, Gege Shi, Jiaxin Shi, et al.
Journal of Pharmaceutical Analysis
|
March 27, 2026
A novel proteolysis-targeting chimera strategy targeting multiple immune checkpoints containing ITIMs enhances antitumor immunity
Yue-Yuan Qiu, Zhao-Wei Wang, Lei He, et al.
Cell Communication and Signaling : CCS
|
October 15, 2025
GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinoma
Gege Shi, Wangqian Zhang, Fei Xie, et al.
Biochemical Pharmacology
|
January 20, 2026
Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunity
Maorong Zhu, Yuxin Wu, Kuo Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 5, 2024
Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
Lei He, Zhaozhao Li, Danjie Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 19, 2026
Uncomplicated Choledocholithiasis in Elderly Patients: A Target Trial Emulation Comparing Observation and ERCP (CHOIcE)
Zachary L Smith, Tasmia Amjad, Mikaela Hoard, et al.
Lancet Regional Health. Americas
|
December 26, 2025
The longitudinal effect of repetition and practice on the accuracy of lay anal examinations for detecting perianal and anal canal abnormalities: a prospective study
Alan G Nyitray, Timothy L McAuliffe, Jenna Nitkowski, et al.
Page
of 9